Type I interferon receptor (IFNAR2) deficiency reveals Zika virus cytopathicity in human macrophages and microglia

Macrophages are key target cells of Zika virus (ZIKV) infection, implicated as a viral reservoir seeding sanctuary sites such as the central nervous system and testes. This rests on the apparent ability of macrophages to sustain ZIKV replication without experiencing cytopathic effects. ZIKV infectio...

Full description

Bibliographic Details
Main Authors: Hanrath, AT, Hatton, CF, Gothe, F, Browne, C, Vowles, J, Leary, P, Cockell, SJ, Cowley, SA, James, WS, Hambleton, S, Duncan, CJA
Format: Journal article
Language:English
Published: Frontiers Media 2022
_version_ 1797109423529787392
author Hanrath, AT
Hatton, CF
Gothe, F
Browne, C
Vowles, J
Leary, P
Cockell, SJ
Cowley, SA
James, WS
Hambleton, S
Duncan, CJA
author_facet Hanrath, AT
Hatton, CF
Gothe, F
Browne, C
Vowles, J
Leary, P
Cockell, SJ
Cowley, SA
James, WS
Hambleton, S
Duncan, CJA
author_sort Hanrath, AT
collection OXFORD
description Macrophages are key target cells of Zika virus (ZIKV) infection, implicated as a viral reservoir seeding sanctuary sites such as the central nervous system and testes. This rests on the apparent ability of macrophages to sustain ZIKV replication without experiencing cytopathic effects. ZIKV infection of macrophages triggers an innate immune response involving type I interferons (IFN-I), key antiviral cytokines that play a complex role in ZIKV pathogenesis in animal models. To investigate the functional role of the IFN-I response we generated human induced pluripotent stem cell (iPSC)-derived macrophages from a patient with complete deficiency of <i>IFNAR2</i>, the high affinity IFN-I receptor subunit. Accompanying the profound defect of IFN-I signalling in <i>IFNAR2</i> deficient iPS-macrophages we observed significantly enhanced ZIKV replication and cell death, revealing the inherent cytopathicity of ZIKV towards macrophages. These observations were recapitulated by genetic and pharmacological ablation of IFN-I signalling in control iPS-macrophages and extended to a model of iPS-microglia. Thus, the capacity of macrophages to support noncytolytic ZIKV replication depends on an equilibrium set by IFN-I, suggesting that innate antiviral responses might counterintuitively promote ZIKV persistence <i>via</i> the maintenance of tissue viral reservoirs relevant to pathogenesis.
first_indexed 2024-03-07T07:40:13Z
format Journal article
id oxford-uuid:f2d7c9ba-b443-4554-a64f-f80da3216b34
institution University of Oxford
language English
last_indexed 2024-03-07T07:40:13Z
publishDate 2022
publisher Frontiers Media
record_format dspace
spelling oxford-uuid:f2d7c9ba-b443-4554-a64f-f80da3216b342023-04-18T14:33:18ZType I interferon receptor (IFNAR2) deficiency reveals Zika virus cytopathicity in human macrophages and microgliaJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:f2d7c9ba-b443-4554-a64f-f80da3216b34EnglishSymplectic ElementsFrontiers Media2022Hanrath, ATHatton, CFGothe, FBrowne, CVowles, JLeary, PCockell, SJCowley, SAJames, WSHambleton, SDuncan, CJAMacrophages are key target cells of Zika virus (ZIKV) infection, implicated as a viral reservoir seeding sanctuary sites such as the central nervous system and testes. This rests on the apparent ability of macrophages to sustain ZIKV replication without experiencing cytopathic effects. ZIKV infection of macrophages triggers an innate immune response involving type I interferons (IFN-I), key antiviral cytokines that play a complex role in ZIKV pathogenesis in animal models. To investigate the functional role of the IFN-I response we generated human induced pluripotent stem cell (iPSC)-derived macrophages from a patient with complete deficiency of <i>IFNAR2</i>, the high affinity IFN-I receptor subunit. Accompanying the profound defect of IFN-I signalling in <i>IFNAR2</i> deficient iPS-macrophages we observed significantly enhanced ZIKV replication and cell death, revealing the inherent cytopathicity of ZIKV towards macrophages. These observations were recapitulated by genetic and pharmacological ablation of IFN-I signalling in control iPS-macrophages and extended to a model of iPS-microglia. Thus, the capacity of macrophages to support noncytolytic ZIKV replication depends on an equilibrium set by IFN-I, suggesting that innate antiviral responses might counterintuitively promote ZIKV persistence <i>via</i> the maintenance of tissue viral reservoirs relevant to pathogenesis.
spellingShingle Hanrath, AT
Hatton, CF
Gothe, F
Browne, C
Vowles, J
Leary, P
Cockell, SJ
Cowley, SA
James, WS
Hambleton, S
Duncan, CJA
Type I interferon receptor (IFNAR2) deficiency reveals Zika virus cytopathicity in human macrophages and microglia
title Type I interferon receptor (IFNAR2) deficiency reveals Zika virus cytopathicity in human macrophages and microglia
title_full Type I interferon receptor (IFNAR2) deficiency reveals Zika virus cytopathicity in human macrophages and microglia
title_fullStr Type I interferon receptor (IFNAR2) deficiency reveals Zika virus cytopathicity in human macrophages and microglia
title_full_unstemmed Type I interferon receptor (IFNAR2) deficiency reveals Zika virus cytopathicity in human macrophages and microglia
title_short Type I interferon receptor (IFNAR2) deficiency reveals Zika virus cytopathicity in human macrophages and microglia
title_sort type i interferon receptor ifnar2 deficiency reveals zika virus cytopathicity in human macrophages and microglia
work_keys_str_mv AT hanrathat typeiinterferonreceptorifnar2deficiencyrevealszikaviruscytopathicityinhumanmacrophagesandmicroglia
AT hattoncf typeiinterferonreceptorifnar2deficiencyrevealszikaviruscytopathicityinhumanmacrophagesandmicroglia
AT gothef typeiinterferonreceptorifnar2deficiencyrevealszikaviruscytopathicityinhumanmacrophagesandmicroglia
AT brownec typeiinterferonreceptorifnar2deficiencyrevealszikaviruscytopathicityinhumanmacrophagesandmicroglia
AT vowlesj typeiinterferonreceptorifnar2deficiencyrevealszikaviruscytopathicityinhumanmacrophagesandmicroglia
AT learyp typeiinterferonreceptorifnar2deficiencyrevealszikaviruscytopathicityinhumanmacrophagesandmicroglia
AT cockellsj typeiinterferonreceptorifnar2deficiencyrevealszikaviruscytopathicityinhumanmacrophagesandmicroglia
AT cowleysa typeiinterferonreceptorifnar2deficiencyrevealszikaviruscytopathicityinhumanmacrophagesandmicroglia
AT jamesws typeiinterferonreceptorifnar2deficiencyrevealszikaviruscytopathicityinhumanmacrophagesandmicroglia
AT hambletons typeiinterferonreceptorifnar2deficiencyrevealszikaviruscytopathicityinhumanmacrophagesandmicroglia
AT duncancja typeiinterferonreceptorifnar2deficiencyrevealszikaviruscytopathicityinhumanmacrophagesandmicroglia